Pacific Shuanglin Bio pharmacy Co Ltd (000403) — Financial Flexibility Index
Pacific Shuanglin Bio pharmacy Co Ltd (000403) has a Financial Flexibility Index of 0.09x as of September 2025. Free cash flow of CN¥142.45 Million (operating CF CN¥70.28 Million minus capex CN¥72.17 Million) represents 0% of total liabilities (CN¥1.55 Billion). Check Pacific Shuanglin Bio pharmacy Co Ltd PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Pacific Shuanglin Bio pharmacy Co Ltd Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Pacific Shuanglin Bio pharmacy Co Ltd across 28 annual periods. See Pacific Shuanglin Bio pharmacy Co Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Pacific Shuanglin Bio pharmacy Co Ltd (1998–2025)
Year-by-year free cash flow to debt coverage for Pacific Shuanglin Bio pharmacy Co Ltd. For the full company profile including market capitalisation, see market cap of Pacific Shuanglin Bio pharmacy Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.08x | CN¥117.41 Million | CN¥-215.99 Million | CN¥1.39 Billion | ▼ -86.6% |
| 2024 | 0.63x | CN¥842.50 Million | CN¥321.79 Million | CN¥1.33 Billion | ▼ -27.5% |
| 2023 | 0.87x | CN¥1.06 Billion | CN¥679.01 Million | CN¥1.21 Billion | ▲ +8.5% |
| 2022 | 0.81x | CN¥902.86 Million | CN¥524.22 Million | CN¥1.12 Billion | ▼ -16.7% |
| 2021 | 0.97x | CN¥734.38 Million | CN¥408.22 Million | CN¥760.07 Million | ▲ +181.9% |
| 2020 | 0.34x | CN¥235.02 Million | CN¥194.84 Million | CN¥685.71 Million | ▼ -30.5% |
| 2019 | 0.49x | CN¥231.96 Million | CN¥190.84 Million | CN¥470.04 Million | ▲ +127.2% |
| 2018 | 0.22x | CN¥151.65 Million | CN¥116.63 Million | CN¥698.08 Million | ▲ +4079.0% |
| 2017 | 0.01x | CN¥3.96 Million | CN¥-35.91 Million | CN¥761.70 Million | ▼ -97.7% |
| 2016 | 0.23x | CN¥160.52 Million | CN¥62.49 Million | CN¥696.41 Million | ▲ +31.5% |
| 2015 | 0.18x | CN¥129.70 Million | CN¥70.31 Million | CN¥739.82 Million | ▼ -13.0% |
| 2014 | 0.20x | CN¥148.09 Million | CN¥77.04 Million | CN¥735.16 Million | ▼ -33.7% |
| 2013 | 0.30x | CN¥254.00 Million | CN¥91.01 Million | CN¥835.47 Million | ▼ -21.8% |
| 2012 | 0.39x | CN¥303.53 Million | CN¥123.24 Million | CN¥780.27 Million | ▲ +29.5% |
| 2011 | 0.30x | CN¥203.72 Million | CN¥130.14 Million | CN¥678.06 Million | ▲ +322.4% |
| 2010 | 0.07x | CN¥46.34 Million | CN¥9.88 Million | CN¥651.42 Million | ▼ -56.5% |
| 2009 | 0.16x | CN¥182.16 Million | CN¥111.86 Million | CN¥1.11 Billion | ▲ +43.2% |
| 2008 | 0.11x | CN¥118.49 Million | CN¥74.90 Million | CN¥1.04 Billion | ▲ +85.9% |
| 2007 | 0.06x | CN¥101.34 Million | CN¥95.03 Million | CN¥1.65 Billion | ▲ +3801.9% |
| 2006 | 0.00x | CN¥-2.88 Million | CN¥-10.42 Million | CN¥1.73 Billion | ▼ -105.8% |
| 2005 | 0.03x | CN¥56.01 Million | CN¥49.06 Million | CN¥1.97 Billion | ▲ +216.0% |
| 2004 | -0.02x | CN¥-37.09 Million | CN¥-131.73 Million | CN¥1.51 Billion | ▼ -132.8% |
| 2003 | 0.07x | CN¥104.70 Million | CN¥-49.47 Million | CN¥1.40 Billion | ▼ -77.0% |
| 2002 | 0.32x | CN¥248.27 Million | CN¥159.18 Million | CN¥765.52 Million | ▲ +12.4% |
| 2001 | 0.29x | CN¥199.24 Million | CN¥111.28 Million | CN¥690.82 Million | ▲ +98.9% |
| 2000 | 0.14x | CN¥83.98 Million | CN¥27.36 Million | CN¥579.29 Million | ▲ +9.6% |
| 1999 | 0.13x | CN¥63.35 Million | CN¥-23.08 Million | CN¥478.92 Million | ▲ +344.3% |
| 1998 | 0.03x | CN¥8.58 Million | CN¥-2.65 Million | CN¥288.28 Million | — |